+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Allogeneic Stem Cells Market - Global Forecast 2026-2032- Product Image
Allogeneic Stem Cells Market - Global Forecast 2026-2032- Product Image
New

Allogeneic Stem Cells Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 185 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6015053
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The allogeneic stem cells market is experiencing rapid transformation as scientific advancements increasingly intersect with operational, commercial, and regulatory priorities. Senior leaders evaluating this sector must understand how evolving technologies, market dynamics, and global policy shifts inform critical investment and partnership decisions.

Market Snapshot: Allogeneic Stem Cells Market Overview

The Allogeneic Stem Cells Market expanded from USD 393.14 million in 2025 to USD 471.37 million in 2026 and is projected to sustain a CAGR of 19.46%, reaching USD 1.36 billion by 2032. This growth is driven by heightened clinical validation, streamlined manufacturing paradigms, and a modernizing global regulatory landscape, collectively enabling broader therapeutic relevance, improved scalability, and increased market accessibility.

Scope & Segmentation

  • Tissue Origin: Hematopoietic stem cells (divided by bone marrow and peripheral blood sources), and mesenchymal stem cells (sourced from adipose tissue, bone marrow, and umbilical cord).
  • Therapeutic Application: Cardiovascular treatments (including myocardial and arterial conditions), immunotherapies (CAR-T, dendritic cell, and NK cell therapies), neurological disorders (Alzheimer’s, Parkinson’s, spinal cord injury), orthopedic strategies, and wound healing approaches.
  • Product Form: Cryopreserved, freeze-dried, and fresh allogeneic cell therapies, each shaping supply-chain handling and clinical deployment.
  • Distribution Routes: Direct sales channels, distributor partnerships, and online distribution mechanisms, adjusting to specific end-user needs.
  • End-User Profile: Contract manufacturing organizations, hospitals and clinics, and research institutes inform commercialization and support requirements.
  • Regional Coverage: Americas, Europe Middle East and Africa, and Asia-Pacific, each presenting unique clinical execution, regulatory, and reimbursement landscapes.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Integrated advances in scientific validation, scalable bioprocessing, and updated regulatory frameworks are enabling a shift from proof-of-concept studies to commercially viable clinical programs.
  • Therapeutic indications are shaped by tissue source and product form, which directly impact manufacturing complexity, logistical requirements, and eventual patient access.
  • Collaborative models linking biopharma, contract manufacturers, and academic partners accelerate product development, while also fostering innovation in niche applications.
  • Successful market entry now requires alignment across analytical rigor, regional manufacturing strategies, and payer-oriented clinical evidence, rather than relying on technology development alone.
  • Real-world evidence is increasingly central to payer adoption, incentivizing longitudinal data capture and health-economic outcome tracking within clinical programs.
  • Regional strategies, particularly in regulatory and reimbursement planning, must adjust to local requirements in supply chain design and evidence generation.

Tariff Impact: Navigating Supply Chain and Vendor Strategy

Recent tariff adjustments and changes to cross-border trade policy are compelling sponsors to refine supply chain strategies. Companies are prioritizing supply chain resilience, qualifying alternative suppliers, and implementing regional buffer inventories to mitigate customs delays and maintain manufacturing continuity. Early engagement in regulatory documentation harmonization supports smoother customs processing, while strategic selection of regional manufacturing hubs enhances flexibility and risk mitigation in procurement and logistics planning.

Methodology & Data Sources

This report applies a mixed-method approach, synthesizing structured interviews with industry executives, manufacturing specialists, and regulatory professionals alongside peer-reviewed literature, regulatory guidance, and clinical trial registry reviews. Qualitative coding and process mapping underpin operational insights, with triangulation ensuring validity across all analytic conclusions.

Why This Report Matters

  • Offers actionable frameworks to align scientific, operational, and commercial strategies within the allogeneic stem cell market.
  • Empowers executives to make informed decisions on tissue sourcing, clinical program design, and regional supply-chain optimization.
  • Enhances risk management by clarifying tariff sensitivity, vendor diversification, and evidence-generation approaches in a dynamic regulatory context.

Conclusion

The successful translation of scientific advances in allogeneic stem cell therapy relies on deliberate integration of analytical, manufacturing, and commercial strategies. Senior leaders equipped with this report’s actionable guidance can prioritize investments, partnerships, and operational frameworks that improve clinical delivery and scale sustainable market adoption.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Allogeneic Stem Cells Market, by Tissue Type
8.1. Hematopoietic Stem Cells
8.1.1. Bone Marrow
8.1.2. Peripheral Blood
8.2. Mesenchymal Stem Cells
8.2.1. Adipose Tissue
8.2.2. Bone Marrow
8.2.3. Umbilical Cord
9. Allogeneic Stem Cells Market, by Application
9.1. Cardiovascular
9.1.1. Myocardial Infarction
9.1.2. Peripheral Arterial Disease
9.2. Immunotherapy
9.2.1. CAR-T Therapies
9.2.2. Dendritic Cell Therapies
9.2.3. NK Cell Therapies
9.3. Neurological Disorders
9.3.1. Alzheimers Disease
9.3.2. Multiple Sclerosis
9.3.3. Parkinsons Disease
9.3.4. Spinal Cord Injury
9.4. Orthopedics
9.4.1. Bone Regeneration
9.4.2. Cartilage Repair
9.4.3. Spine Fusion
9.5. Wound Healing
9.5.1. Burn Wounds
9.5.2. Chronic Wounds
9.5.3. Diabetic Foot Ulcers
10. Allogeneic Stem Cells Market, by Source
10.1. Adipose Tissue
10.2. Bone Marrow
10.3. Peripheral Blood
10.4. Umbilical Cord
11. Allogeneic Stem Cells Market, by Product Type
11.1. Cryopreserved
11.2. Freeze Dried
11.3. Fresh
12. Allogeneic Stem Cells Market, by End-User
12.1. Contract Manufacturing Organizations
12.2. Hospitals and Clinics
12.3. Research Institutes
13. Allogeneic Stem Cells Market, by Distribution Channel
13.1. Offline
13.2. Online
14. Allogeneic Stem Cells Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Allogeneic Stem Cells Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Allogeneic Stem Cells Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Allogeneic Stem Cells Market
18. China Allogeneic Stem Cells Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Allogene Therapeutics, Inc.
19.6. Athersys, Inc.
19.7. Celularity, Inc.
19.8. Cynata Therapeutics Limited
19.9. Fate Therapeutics, Inc.
19.10. Gamida Cell Ltd.
19.11. Mesoblast Limited
19.12. Osiris Therapeutics, Inc.
19.13. Pluristem Therapeutics, Inc.
19.14. TiGenix N.V.
List of Figures
FIGURE 1. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ALLOGENEIC STEM CELLS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ALLOGENEIC STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES ALLOGENEIC STEM CELLS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA ALLOGENEIC STEM CELLS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE MARROW, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE MARROW, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE MARROW, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE MARROW, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CAR-T THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CAR-T THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CAR-T THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DENDRITIC CELL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DENDRITIC CELL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DENDRITIC CELL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY NK CELL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY NK CELL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY NK CELL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ALZHEIMERS DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ALZHEIMERS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ALZHEIMERS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PARKINSONS DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PARKINSONS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PARKINSONS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY SPINAL CORD INJURY, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY SPINAL CORD INJURY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY SPINAL CORD INJURY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE REGENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE REGENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CARTILAGE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CARTILAGE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY SPINE FUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY SPINE FUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY SPINE FUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BURN WOUNDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BURN WOUNDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BURN WOUNDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CHRONIC WOUNDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CHRONIC WOUNDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CHRONIC WOUNDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DIABETIC FOOT ULCERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DIABETIC FOOT ULCERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DIABETIC FOOT ULCERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE MARROW, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY BONE MARROW, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY UMBILICAL CORD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CRYOPRESERVED, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CRYOPRESERVED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CRYOPRESERVED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY FREEZE DRIED, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY FREEZE DRIED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY FREEZE DRIED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY FRESH, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY FRESH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY FRESH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. EUROPE ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. EUROPE ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2032 (USD MILLION)
TABLE 191. EUROPE ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2032 (USD MILLION)
TABLE 192. EUROPE ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 193. EUROPE ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. EUROPE ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 195. EUROPE ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 196. EUROPE ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 197. EUROPE ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 198. EUROPE ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
TABLE 199. EUROPE ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 200. EUROPE ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 201. EUROPE ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 202. EUROPE ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 217. AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 218. AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2032 (USD MILLION)
TABLE 219. AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2032 (USD MILLION)
TABLE 220. AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 221. AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 222. AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 223. AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 224. AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 225. AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 226. AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
TABLE 227. AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 228. AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 229. AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 230. AFRICA ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 239. ASIA-PACIFIC ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 240. ASIA-PACIFIC ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 245. GLOBAL ALLOGENEIC STEM CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 246. ASEAN ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. ASEAN ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2032 (USD MILLION)
TABLE 248. ASEAN ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2032 (USD MILLION)
TABLE 249. ASEAN ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 250. ASEAN ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 251. ASEAN ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 252. ASEAN ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 253. ASEAN ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 254. ASEAN ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 255. ASEAN ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
TABLE 256. ASEAN ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 257. ASEAN ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 258. ASEAN ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 259. ASEAN ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 260. GCC ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 261. GCC ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2032 (USD MILLION)
TABLE 262. GCC ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2032 (USD MILLION)
TABLE 263. GCC ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 264. GCC ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 265. GCC ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 266. GCC ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 267. GCC ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 268. GCC ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 269. GCC ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
TABLE 270. GCC ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 271. GCC ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 272. GCC ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 273. GCC ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 288. BRICS ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 289. BRICS ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2032 (USD MILLION)
TABLE 290. BRICS ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2032 (USD MILLION)
TABLE 291. BRICS ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 292. BRICS ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 293. BRICS ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 294. BRICS ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 295. BRICS ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 296. BRICS ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 297. BRICS ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
TABLE 298. BRICS ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 299. BRICS ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 300. BRICS ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 301. BRICS ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 302. G7 ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 303. G7 ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2032 (USD MILLION)
TABLE 304. G7 ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2032 (USD MILLION)
TABLE 305. G7 ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 306. G7 ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 307. G7 ALLOGENEIC STEM CELLS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 308. G7 ALLOGENEIC STEM CELLS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
TABLE 309. G7 ALLOGENEIC STEM CELLS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 310. G7 ALLOGENEIC STEM CELLS MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
TABLE 311. G7 ALLOGENEIC STEM CELLS MARKET SIZE, BY WOUND HEALING, 2018-2032 (USD MILLION)
TABLE 312. G7 ALLOGENEIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 313. G7 ALLOGENEIC STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 314. G7 ALLOGENEIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 315. G7 ALLOGENEIC STEM CELLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 316. NATO ALLOGENEIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 317. NATO ALLOGENEIC STEM CELLS MARKET SIZE, BY TISSUE TYPE, 2018-2032 (USD MILLION)
TABLE 318. NATO ALLOGENEIC STEM CELLS MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, 2018-2032 (USD MILLION)
TABLE 319. NATO ALLOGENEIC STEM CELLS MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2032 (USD MILLION)
TABLE 320. NATO ALLOGENEIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 321. NATO

Companies Mentioned

The key companies profiled in this Allogeneic Stem Cells market report include:
  • Allogene Therapeutics, Inc.
  • Athersys, Inc.
  • Celularity, Inc.
  • Cynata Therapeutics Limited
  • Fate Therapeutics, Inc.
  • Gamida Cell Ltd.
  • Mesoblast Limited
  • Osiris Therapeutics, Inc.
  • Pluristem Therapeutics, Inc.
  • TiGenix N.V.

Table Information

Report AttributeDetails
No. of Pages185
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 471.37 Million
Forecasted Market Value ( USD ) by 2032 $ 1360 Million
Compound Annual Growth Rate19.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Stem Cell Manufacturing Market - Global Forecast 2026-2032 - Product Image

Stem Cell Manufacturing Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Mesenchymal Stem Cell Drugs Market - Global Forecast 2025-2030 - Product Image

Mesenchymal Stem Cell Drugs Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Allogeneic Stem Cells - Global Strategic Business Report - Product Image

Allogeneic Stem Cells - Global Strategic Business Report

  • Report
  • 171 Pages
  • Global
From
Stem Cell Therapy Market Report and Forecast 2025-2034 - Product Image

Stem Cell Therapy Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Allogeneic Hematopoietic Stem Cell Transplant Market: Focus on Country and Regional Analysis, 2025-2035 - Product Image

Allogeneic Hematopoietic Stem Cell Transplant Market: Focus on Country and Regional Analysis, 2025-2035

  • Report
  • Global
From

About the Allogeneic Stem Cells Market

Allogeneic stem cells are stem cells derived from a donor, typically from a family member, and used to treat a variety of diseases and conditions. Allogeneic stem cells are used in a variety of medical treatments, including bone marrow transplants, cancer treatments, and regenerative medicine. Allogeneic stem cells are also used in research to study the effects of stem cells on diseases and conditions. The allogeneic stem cell market is a rapidly growing field, with a variety of companies offering products and services related to stem cell research and treatments. Companies in the allogeneic stem cell market include Celgene, Novartis, and Osiris Therapeutics, which offer products and services related to stem cell research and treatments. Other companies in the market include BioTime, Athersys, and Mesoblast, which offer products and services related to stem cell therapies. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.